End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients

Figure 1 Bar diagram of post endoscopic retrograde cholangiopancreatography adverse events and hospital mortality percentages between end-stage renal disease, chronic kidney disease, and control. CKD: Chronic kidney disease; ESRD: End-stage renal disease; PEP: Post endoscopic retrograde cholangiopancreatography pancreatitis.